Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 16Recruiting 7Unknown 5Terminated 4Withdrawn 3Not yet recruiting 3Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Early-stage Peripheral Non-small Cell Lung Cancer 1

Interventions

Cisplatin 9Specimen Handling 7Educational Status 7Standard of Care 6Interviews as Topic 6Drug Therapy 6Carboplatin 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Observation 4Lenalidomide 4Fluorouracil 4Dexamethasone 4pembrolizumab 3lenvatinib 3camrelizumab 3Surveys and Questionnaires 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Gemcitabine 3Fluorodeoxyglucose F18 3Exercise 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Drug Delivery Systems × Clear all
NCT07167459 2025-09-11

Personalized SBRT in Early-Stage Peripheral NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Enrolling by invitation
251 enrolled
Thoracic

Early-stage Peripheral Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡